Advances in neurotrauma.
Neurotrauma advances in 1992 include further elucidation and understanding of the pathophysiologic processes involved in head and spine trauma, major contributions from multicenter clinical pharmacologic trials, and significant refinement of acute management principles. This article integrates the neurotrauma advances of 1992 in the context of the daily treatment of patients with head and spinal cord injuries.
Wilberger
J
J
Allegheny General Hospital and Medical College of Pennsylvania, Pittsburgh, USA.
D002545:Brain Ischemia / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology; D002491:Central Nervous System Agents / Q000627:therapeutic use; D015600:Glasgow Coma Scale; D005973:Glutamine / Q000502:physiology; D016489:Head Injuries, Closed / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D007427:Intracranial Pressure / Q000187:drug effects / Q000502:physiology; D007511:Ischemia / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D013116:Spinal Cord / Q000098:blood supply; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D015996:Survival Rate
D002491:Central Nervous System Agents; D018836:Inflammation Mediators; D005973:Glutamine